IP Verse

Oral Pharmaceutical Compositions Of Dabigatran Etexilate - EP2817000

PATENT ANALYSIS

Patent Details

Grant Date
Aug 4, 2021
Company
ESTEVE PHARMACEUTICALS, S.A.
Oppositions

AERA A/S

GLENMARK PHARMACEUTICALS EUROPE LTD

HAMM&WITTKOPP PATENTANWALTE PARTMBB

More patents of Esteve Pharmaceuticals, S.A.

EP2817000

Want to monitor this patent?

Feel free to send us a message here and we will get back to you